Literature DB >> 31111795

Prospective Validation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults.

Mira Minkkinen1, Grant L Iverson2, Anna-Kerttu Kotilainen1, Satu-Liisa Pauniaho3, Ville M Mattila1,4, Terho Lehtimäki1,5, Ksenia Berghem6, Jussi P Posti7, Teemu M Luoto8.   

Abstract

The Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults (Scandinavian guidelines) are the first to incorporate serum measurement of the S100 astroglial calcium-binding protein B (S100B) to emergency department (ED) triage of patients with head injury (HI). This prospective validation study was conducted in the ED of the Tampere University Hospital, Finland, between November 2015 and November 2016. All consecutive adult patients with HI presenting to the ED within 24 h from injury were eligible for inclusion. Venous blood for S100B sampling was drawn from all patients, and the result was available at the ED. Computed tomography (CT) scans of the head were performed according to the on-call physician's evaluation. Only the samples collected within 6 h after injury were used. A one-week follow-up was conducted to identify possible HI-related complications. A total of 295 patients (median age, 67.0 years, range, 18-100; women, 48.8%) were enrolled. Of those, 196 (66.4%) underwent scanning. Acute traumatic lesions were detected on 31 (15.8%) of the scans. Two of the CT-positive patients were scanned without a guidelines-based indication. These lesions did not require any specific treatment or repeated imaging. The guidelines-based sensitivity was 0.94 (95% confidence interval [CI], 0.77-0.99) and specificity 0.19 (95% CI, 0.13-0.26) for predicting traumatic intracranial CT abnormalities. The positive and negative predictive value for positive head CT was 0.18 (95% CI, 0.12-0.25) and 0.94 (95% CI, 0.78-0.99), respectively. In the mild-low risk group, no false negative S100B values were recorded. Thirteen patients (4.4%) were re-admitted to the ED, and two patients (0.7%) died one week after the primary HI. The deaths were unrelated to the injury. None of these adverse events were directly caused by a primarily undiagnosed intracranial injury. The Scandinavian guidelines incorporated with S100B are a valid means of screening clinically significant acute traumatic lesions after HI and have the potential to reduce unnecessary CT scanning.

Entities:  

Keywords:  brain injury; computed tomography; emergency treatment; guideline; head injury

Year:  2019        PMID: 31111795     DOI: 10.1089/neu.2018.6351

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

Review 1.  S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.

Authors:  Michael Amoo; Jack Henry; Philip J O'Halloran; Paul Brennan; Mohammed Ben Husien; Matthew Campbell; John Caird; Mohsen Javadpour; Gerard F Curley
Journal:  Neurosurg Rev       Date:  2021-10-28       Impact factor: 3.042

2.  [GCS score combined with CT score and serum S100B protein level Can evaluate severity and early prognosis of acute traumatic brain injury].

Authors:  W Yin; S Weng; S Lai; H Nie
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-04-20

3.  Serum metabolome associated with severity of acute traumatic brain injury.

Authors:  Ilias Thomas; Alex M Dickens; Jussi P Posti; Endre Czeiter; Daniel Duberg; Tim Sinioja; Matilda Kråkström; Isabel R A Retel Helmrich; Kevin K W Wang; Andrew I R Maas; Ewout W Steyerberg; David K Menon; Olli Tenovuo; Tuulia Hyötyläinen; András Büki; Matej Orešič
Journal:  Nat Commun       Date:  2022-05-10       Impact factor: 17.694

Review 4.  Neurologic Assessment of the Neurocritical Care Patient.

Authors:  Shane Musick; Anthony Alberico
Journal:  Front Neurol       Date:  2021-03-22       Impact factor: 4.003

5.  GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask.

Authors:  Damir Janigro; Stefania Mondello; Jussi P Posti; Johan Unden
Journal:  Front Neurol       Date:  2022-03-21       Impact factor: 4.003

6.  A multi-staged neuropeptide response to traumatic brain injury.

Authors:  José Luís Alves; João Mendes; Ricardo Leitão; Ana Paula Silva; Anabela Mota Pinto
Journal:  Eur J Trauma Emerg Surg       Date:  2020-08-01       Impact factor: 3.693

7.  Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.

Authors:  Endre Czeiter; Krisztina Amrein; Benjamin Y Gravesteijn; Fiona Lecky; David K Menon; Stefania Mondello; Virginia F J Newcombe; Sophie Richter; Ewout W Steyerberg; Thijs Vande Vyvere; Jan Verheyden; Haiyan Xu; Zhihui Yang; Andrew I R Maas; Kevin K W Wang; András Büki
Journal:  EBioMedicine       Date:  2020-05-25       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.